Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes-Reference-Cited by-同舟云学术

Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

Published:2014-12 Issue:6 Volume:16 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Timms Kirsten M,Abkevich Victor,Hughes Elisha,Neff Chris,Reid Julia,Morris Brian,Kalva Saritha,Potter Jennifer,Tran Thanh V,Chen Jian,Iliev Diana,Sangale Zaina,Tikishvili Eliso,Perry Michael,Zharkikh Andrey,Gutin Alexander,Lanchbury Jerry S

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1186/s13058-014-0475-x/fulltext.html

Reference15 articles.

1. Fong PF, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JHM, de Bono JS: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. NEJM. 2009, 361: 123-134. 10.1056/NEJMoa0900212.

2. Byrski T, Gronwald J, Huzarski R, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wisniowski R, Siolek M, Dent R, Lubinski J, Narod S: Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol. 2010, 28: 375-379. 10.1200/JCO.2008.20.7019.

3. Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Aksien LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003, 95: 1482-1485. 10.1093/jnci/djg050.

4. Comen EA, Davids M, Kirchhoff T, Balistreri L, Hanse J, Kosarin K, Offit K, Robson ME: Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer [abstract]. J Clin Oncol. 2008, 26: 22002-

5. Atchley DP, Albarracin ET, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GM, Arun BK: Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol. 2008, 26: 4282-4288. 10.1200/JCO.2008.16.6231.

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors;Journal of the National Cancer Center;2024-09

2. Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches;Frontiers in Oncology;2024-08-16

3. Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over;Gynecologic Oncology;2024-08

4. Prevalence of homologous recombination biomarkers in multiple tumor types: an observational study;Future Oncology;2024-07-16

5. AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China;European Journal of Medical Research;2024-07-16